AYUSH Ministry asks Patanjali to stop advertising Covid-19 drug
24 June, 2020 | newsx bureau
Green signal to be granted on 'Coronil and Swasari' only after report is approved for claims, good that Patanjali has taken the initiative, says MoS Shripad Naik.
MoS for the Union Ayush Ministry Shripad Naik on Wednesday said that his Ministry will clear its stance on pharmaceutical giant Patanjali’s newly-launched ayurvedic drugs ‘Coronil and Swasari’ for the novel coronavirus after reviewing the report sent by it.
However, the Minister said that it is good that Baba Ramdev has given a new medicine to the country.
“It is a good thing that Baba Ramdev has given a new medicine to the country but as per rule, it has to come to AYUSH Ministry first. They even said that they have sent a report. We will look into it and permission will be given after seeing the report,” Naik told ANI.
The AYUSH Ministry had said on Tuesday that it has taken cognizance of news in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd, Haridwar and said the company has been asked to “stop advertising/publicising such claims till the issue is duly examined”.
Also read: Politics after LAC rages on, Chidambaram hits out at BJP President over ‘Chinese intrusions
Also read: Amid boycott calls, Govt asks companies to spell out “Country of Origin”
In a release, the Ministry said that facts of the claim and details of the stated scientific study are not known to it.
It had said the concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and directives issued by the Central government in the wake of COVID outbreak.
The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on COVID-19 with AYUSH interventions/medicines should be undertaken.
The release had said that Patanjali Ayurved has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment, places where the research study was conducted for COVID-19, protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study and “stop advertising/publicising such claims till the issue is duly examined.
The Ministry had also requested concerned state licensing authority of Uttrakhand to provide copies of license and product approval details of Ayurvedic medicines being claimed for the treatment of COVID-19.
Patanjali Ayurved on Tuesday launched ‘Coronil and Swasari’ claiming it to be Ayurvedic cure for treating COVID-19 and said clinical trials have shown favourable results.
Also read: 50,000 Made in India ventilators to be distributed in Covid-19 hospitals through PM-CARES Fund